TIBER CREEK GROUP

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF GENENTECH, INC.) · Government relations.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 18, 2025

Lobbying activity 2

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part B Pricing Reform.

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.